Literature DB >> 29147171

Recent Progress of Bypass Surgery to the Dialysis-Dependent Patients with Critical Limb Ischemia.

Nobuyoshi Azuma1, Shinsuke Kikuchi1, Hiroko Okuda1, Keisuke Miyake1, Atsuhiro Koya1.   

Abstract

According to expansion of dialysis-dependent population, more than half of patients with critical ischemic limbs are dialysis-dependent in Japan. Although patients with end-staged renal disease are well-known as poor life prognosis, well-managed dialysis patients in Japan can survive much longer compared to dialysis patients in the United States and Europe. Therefore, some dialysis patients can enjoy the long-term benefits of bypass surgery. To decide the indication of bypass surgery, patient's general condition, nutrition status, and vein availability are more important rather than arterial disease anatomy. Ultrasound guided nerve block anesthesia blocking both sciatic and femoral nerve is contributing greatly to quick postoperative recovery of high risk patients. Preoperative ultrasound examination also contribute to not only vein mapping but also find out the graftable segment of artery. The selection of distal target should be decided based on the degree of arterial disease (luminal surface as well as wall calcification), and arterial run-off. Several tips regarding anastomosis to heavily calcified artery have been established including how to create bloodless operative field without arterial clamps. Adequate wound management after bypass surgery is also important. Detection of deep infection such as osteomyelitis and the adequate treatment may avoid major amputation of salvageable limbs. In the era of endovascular treatment, the evidences guiding how to select dialysis patients suitable for bypass surgery are awaiting. (This is a translation of Jpn J Vasc Surg 2017; 26: 33-39.).

Entities:  

Keywords:  critical limb ischemia; dialysis-dependent renal failure; distal bypass surgery; limb salvage; peripheral arterial disease

Year:  2017        PMID: 29147171      PMCID: PMC5684170          DOI: 10.3400/avd.ra.17-00076

Source DB:  PubMed          Journal:  Ann Vasc Dis        ISSN: 1881-641X


  19 in total

1.  Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial.

Authors:  D J Adam; J D Beard; T Cleveland; J Bell; A W Bradbury; J F Forbes; F G R Fowkes; I Gillepsie; C V Ruckley; G Raab; H Storkey
Journal:  Lancet       Date:  2005-12-03       Impact factor: 79.321

2.  Current practice of first-line treatment strategies in patients with critical limb ischemia.

Authors:  Theodosios Bisdas; Matthias Borowski; Giovanni Torsello
Journal:  J Vasc Surg       Date:  2015-07-14       Impact factor: 4.268

3.  2014 JAPAN Critical Limb Ischemia Database (JCLIMB) Annual Report.

Authors: 
Journal:  Ann Vasc Dis       Date:  2016-11-25

Review 4.  Ulcer healing after peripheral intervention-can we predict it before revascularization?

Authors:  Nobuyoshi Azuma; Atsuhiro Koya; Daiki Uchida; Yukihiro Saito; Hisashi Uchida
Journal:  Circ J       Date:  2014-07-04       Impact factor: 2.993

5.  Heparin-bonded ePTFE grafts compared with vein grafts in femoropopliteal and femorocrural bypasses: 1- and 2-year results.

Authors:  Kim Daenens; Stijn Schepers; Inge Fourneau; Sabrina Houthoofd; André Nevelsteen
Journal:  J Vasc Surg       Date:  2009-05       Impact factor: 4.268

6.  The prognosis of patients on hemodialysis with foot lesions.

Authors:  Yuki Orimoto; Takashi Ohta; Hiroyuki Ishibashi; Ikuo Sugimoto; Hirohide Iwata; Tetsuya Yamada; Masao Tadakoshi; Noriyuki Hida
Journal:  J Vasc Surg       Date:  2013-06-27       Impact factor: 4.268

7.  Surgical reconstruction versus peripheral intervention in patients with critical limb ischemia - a prospective multicenter registry in Japan: the SPINACH study design and rationale.

Authors:  Nobuyoshi Azuma; Osamu Iida; Mitsuyoshi Takahara; Yoshimitsu Soga; Akio Kodama
Journal:  Vascular       Date:  2014-01-29       Impact factor: 1.285

8.  Clinical outcomes after infrainguinal bypass grafting for critical limb ischaemia in patients with dialysis-dependent end-stage renal failure.

Authors:  A Kodama; M Sugimoto; S Kuma; J Okazaki; S Mii; K Komori
Journal:  Eur J Vasc Endovasc Surg       Date:  2014-10-03       Impact factor: 7.069

9.  Worldwide, mortality risk is high soon after initiation of hemodialysis.

Authors:  Bruce M Robinson; Jinyao Zhang; Hal Morgenstern; Brian D Bradbury; Leslie J Ng; Keith P McCullough; Brenda W Gillespie; Raymond Hakim; Hugh Rayner; Joan Fort; Tadao Akizawa; Francesca Tentori; Ronald L Pisoni
Journal:  Kidney Int       Date:  2013-06-26       Impact factor: 10.612

10.  Vascular Surgery in Japan: 2011 Annual Report by the Japanese Society for Vascular Surgery.

Authors: 
Journal:  Ann Vasc Dis       Date:  2018-09-25
View more
  3 in total

1.  Long-Term Results of Femorotibial Polytetrafluoroethylene Bypass with a Distal Vein Cuff for Critical Limb Ischemia.

Authors:  Atsushi Guntani; Shinsuke Mii; Sosei Kuma; Kiyoshi Tanaka; Akio Kodama; Eisuke Kawakubo
Journal:  Ann Vasc Dis       Date:  2018-09-25

Review 2.  Contemporary critical limb ischemia: Asian multidisciplinary consensus statement on the collaboration between endovascular therapy and wound care.

Authors:  Osami Kawarada; Kan Zen; Koji Hozawa; Shinobu Ayabe; Hsuan-Li Huang; Donghoon Choi; Su Hong Kim; Jiyoun Kim; Taku Kato; Yoshinori Tsubakimoto; Tasuya Nakama; Shigeo Ichihashi; Naoki Fujimura; Akihiro Higashimori; Masahiko Fujihara; Tomoyasu Sato; Bryan Ping-Yen Yan; Skyi Yin-Chun Pang; Chumpol Wongwanit; Yew Pung Leong; Benjamin Chua; Robbie K George; Yoshiaki Yokoi; Hisashi Motomura; Hideaki Obara
Journal:  Cardiovasc Interv Ther       Date:  2018-04-13

3.  Perioperative patient-controlled regional analgesia versus patient-controlled intravenous analgesia for patients with critical limb ischaemia: a study protocol for a randomised controlled trial.

Authors:  Si Chen; Zhonghuang Xu; Hongju Liu; Yuelun Zhang; Jiao Zhang; Yuexin Chen; Yuehong Zheng; Yuguang Huang
Journal:  BMJ Open       Date:  2020-10-08       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.